Protein-Crosslinked Microcapsules for Biodegradable Release Control

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing microcapsules are not biodegradable, leading to environmental buildup, and their performance and integrity are compromised by premature fracture or permeability, limiting their suitability for various applications.

Innovation Solution

Microcapsules are produced using a combination of protein-based components and multiple cross-linking agents, including isocyanates and chloro components, with specific weight ratios to achieve biodegradability and controlled release properties.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If traditional microcapsule walls are made strong and impermeable to prevent premature fracture and leakage, then integrity is improved, but biodegradability deteriorates leading to environmental buildup

Engineering Contradiction:
Improvemicrocapsule integrityVSAvoidenvironmental buildup
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The microcapsule walls are constructed from composite materials comprising protein-based components (such as gelatin, albumin, or casein) crosslinked with biodegradable crosslinking agents. This composite structure provides both the mechanical strength and impermeability needed for integrity while maintaining biodegradability through natural enzyme degradation pathways, thus resolving the contradiction between durability and environmental persistence

Inventive Principle:
Principle #40Composite materials

Solution Approach 2:

The patent employs controlled crosslinking parameters including varying crosslinking agent concentration, crosslinking time, and temperature to optimize the balance between wall strength and biodegradability. By adjusting these parameters, the microcapsule walls achieve sufficient mechanical properties for application-specific integrity while retaining controlled biodegradation rates that prevent environmental accumulation

Inventive Principle:
Principle #35Parameter changes

2Strength

If microcapsule walls are made strong to avoid premature fracture, then strength is improved, but controlled release capability deteriorates

Engineering Contradiction:
Improvemicrocapsule wall strengthVSAvoidcontrolled release duration
Core Design Contradiction:
StrengthVSDuration of action of moving object

Solution Approach 1:

The microcapsule walls exhibit local quality variations through non-uniform crosslinking density distribution. Regions with lower crosslinking density allow controlled permeation and gradual release of encapsulated materials, while overall wall strength is maintained through strategically placed crosslinked regions. This spatial variation in crosslinking density enables simultaneous achievement of structural strength and controlled release functionality

Inventive Principle:
Principle #3Local quality

Solution Approach 2:

The crosslinked protein-based wall structure inherently forms a porous network that allows controlled diffusion of encapsulated materials. The porosity is regulated by crosslinking conditions, creating channels that permit gradual release while the crosslinked structure maintains overall wall integrity and prevents premature fracture, thus resolving the contradiction between strength and release control

Inventive Principle:
Principle #31Porous materials

3Reliability

If microcapsule walls are made impermeable to prevent leakage, then reliability is improved, but biodegradability deteriorates

Engineering Contradiction:
Improvemicrocapsule impermeabilityVSAvoidenvironmental persistence
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent extracts and utilizes natural biodegradation pathways by selecting protein-based components that can be degraded by naturally occurring enzymes in the environment. The crosslinking system is designed to be reversible or cleavable by biological enzymes, allowing the microcapsule walls to maintain impermeability during service life while ultimately breaking down into harmless natural products, thus eliminating environmental persistence

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

By controlling the degree and type of crosslinking, the patent adjusts the balance between impermeability and biodegradability. Moderate crosslinking provides sufficient impermeability for reliable containment during storage and application, while leaving enough uncrosslinked or enzymatically cleavable bonds to allow complete biodegradation in the environment, preventing long-term persistence

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The resulting microcapsules exhibit improved biodegradability, strength, and controlled release characteristics, suitable for a wide range of applications including agrochemicals, pharmaceuticals, and consumer products.

Implementation Method 1

microcapsule walls comprise the reaction product of one or more protein-based components selected from proteins, peptides and/or polypeptides with at least two different cross-linking agents, at least one of which is an isocyanate component and the other of which is a chloro component

Methodology Applied
Scientific EffectCross-linking reaction: Chemical Bonding

Data Source

PatentUS20250302760A1Biodegradable, controlled release microcapsules
Publication Date: 2025.10.02 ENCAPSYS LLC
  • US20250302760A1 patent drawing

AI summary

Controlled release biodegrading microcapsules comprising the reaction product of at least one protein component and a cross-linking component, the cross-linking component comprising at least one isocyanate and at least one of an acid dichloride, a chloroformate and/or a sulfonyl chloride.